🔬
You have used your free lookups for today
Upgrade to BiotechSigns Pro for unlimited company access, full signal history, watchlist alerts, and 125+ PDUFA dates.
Upgrade to Pro →← Back to screener
← Back to Screener
E

ESPR

Esperion Therapeutics
CardiovascularScore: 36/100📋 Full Profile
D
36

What is the current ESPR catalyst setup?

ESPR is tracked by BiotechSigns with a current catalyst score of 36/100 and grade D. The page summarizes 0 active signals, including 0 PDUFA, 0 insider buying, and 0 clinical trial signals, with data refreshed on 2026-06-03.

Analyst Summary
Verified 2026-04-11

Esperion Therapeutics (ESPR) is the lead sponsor of 1 active clinical trials listed on ClinicalTrials.gov[1].

Sources

  1. ClinicalTrials.gov (2026-04-11) ↗
Not financial advice. BiotechSigns scores are for informational purposes only and do not constitute investment recommendations. Always do your own due diligence before making investment decisions.
No active signals for ESPR
Signal Summary
PDUFA0
Insider0
Clinical0
Data Sources
Dilution◌ LOADING
Sentiment◌ LOADING
SEC EDGAR● LIVE
ClinicalTrials● LIVE
Yahoo Finance● LIVE